ARTICLE | Clinical News
Perceiva sirolimus: Completed Phase II enrollment
October 5, 2009 7:00 AM UTC
MacuSight completed enrollment of 143 patients in a placebo-controlled, dose-ranging, U.S. Phase II trial evaluating single subconjunctival injections of Perceiva. ...